Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

DiaMedica Therapeutics Inc (DMAC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow DiaMedica Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.510 +0.120    +5.02%
22/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 21,158
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.260 - 2.560
DiaMedica Therapeutics 2.510 +0.120 +5.02%

DiaMedica Therapeutics Inc Company Profile

 
Get an in-depth profile of DiaMedica Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

19

Equity Type

ORD

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease. The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases. In addition, it develops treatment for neurological disease. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Contact Information

Address 301 Carlson Parkway Suite 210
Minneapolis, 55305
United States
Phone (763) 496-5454
Fax -

Top Executives

Name Age Since Title
R. Michael Giuffre 68 2010 Independent Director
Philip Bath - 2023 Member of Stroke Advisory Board
Richard D. Pilnik 67 2009 Independent Chairman
Charles Herzog - - Member of Kidney Scientific Advisory Board
Aldo Peixoto - 2019 Member of Kidney Scientific Advisory Board
James T. Parsons 59 2015 Independent Director
Dietrich John Pauls 53 2005 President, CEO & Director
John Volpi - - Member of Stroke Clinical Advisory Board
Rajiv Agarwal - 2019 Member of Kidney Scientific Advisory Board
Glenn Matthew Chertow - 2019 Member of Kidney Scientific Advisory Board
Richard Edward Kuntz 67 2023 Independent Director
Scott Eric Kasner - - Member of Stroke Clinical Advisory Board
George L. Bakris - 2019 Member of Kidney Scientific Advisory Board
Charles Pauling Semba 63 2021 Independent Director
Tanya N. Lewis 53 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DMAC Comments

Write your thoughts about DiaMedica Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ab High
Ab High Aug 24, 2021 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What hapened
Ab High
Ab High Aug 13, 2021 4:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ab High
Ab High Jul 06, 2021 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Soon
Ab High
Ab High Jun 30, 2021 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
4.370
Taiseer Fasterz
Taiseer Fasterz Jun 29, 2021 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is there any negative news?
Ab High
Ab High Jun 29, 2021 11:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
4.6
Mr Steel
Mr Steel Dec 22, 2020 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i like what i see
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email